The maker of inhaled insulin Afrezza is betting that relaunching their product and making it a success depends less on d…
Inhaled Insulin
FDA Needs More Time to Review MannKind’s New Drug Application for Inhaled Insulin
MannKind Corp. announced that it was informed today by the FDA that they will not be able to complete the review of Mann…
